Recrudescent tobacco exposure following heart transplantation: Clinical profiles and relationship with athero-thrombosis risk markers

American Journal of Transplantation

Volumn 5, Issue 5, 2005, Pages 1137-1140

  Mehra, Mandeep R ^a   Uber, Patricia A ^a   Prasad, Ananth ^a   Scott, Robert L ^a   Park, Myung H ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Biomarkers; Heart transplant; Tobacco

Indexed keywords

C REACTIVE PROTEIN; CYCLOSPORIN; HOMOCYSTEINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINE; PREDNISONE; TOBACCO SMOKE;

ADULT; ARTICLE; CARDIAC GRAFT REJECTION; COHORT ANALYSIS; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RECIDIVISM; RISK ASSESSMENT; SELF REPORT; SMOKING CESSATION; THROMBOCYTE COUNT; THROMBOSIS;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HEART TRANSPLANTATION; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRES; RISK; RISK FACTORS; SMOKING; SMOKING CESSATION; THROMBOSIS; TIME FACTORS; TOBACCO;

EID: 17644392096     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.00809.x     Document Type: Article

References (11)

1. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004; 43: 1731-1737.
2. Nagele H, Kalmar P, Rodiger W, Stubbe HM. Smoking after heart transplantation: an underestimated hazard. Eur J Cardiothorac Surg 997; 12: 70-74.
3. Costanzo MR, Eisen HG, Brown RN, for the CTRD at UAB. Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7000 cardiac transplant patients. J Heart Lung Transplant 2001; 20: 152-159.
4. Ventura HO, Mehra MR. C-reactive protein and cardiac allograft vasculopathy: is inflammation the critical link? J Am Coll Cardiol 2003; 42: 483-485.
5. Miriuka SG, Delgado DH, Cole DE, Rao V, Ross HJ. Hyperhomocysteinemia in heart transplantation: from bench to bedside. J Heart Lung Transplant 2003; 22: 1069-1081.
6. Mehra MR, Uber PA, Scott RL, Park MH, Milani RV. Effect of immunosuppressive regimen on novel markers of atherothrombosis in heart transplantation: homocysteine, C-reactive protein and mean platelet volume. Transplant Proc 2002; 34: 1866-1868.
7. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002; 4: 149-159.
8. Di Tullio M, Granata D, Taioli E, Broccolino M, Zaini G, Belli C. Early predictors of smoking cessation after myocardial infarction. Clin Cardiol 1991; 14: 809-812.
9. Rigotti NA, McKool KM, Shiftman S. Predictors of smoking cessation after coronary artery bypass graft surgery. Results of a randomized trial with 5-year follow-up. Ann Intern Med 1994; 120: 287-293.
10. Cosio FG, Falkenhain ME, Pesavento TE et al. Patient survival after renal transplantation. The impact of smoking. Clin Transplant 1999; 13: 336-341.
11. Basile A, Bernazzali S, Diciolla F et al. Risk factors for smoking abuse after heart transplantation. Transplant Proc 2004; 36: 641-642.